Shilpa Medicare

29
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
331.65
-1.8 (-0.54%)
BSENSE

Dec 05

BSE+NSE Vol: 1.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
1,151.00
1,050.00
1,145.00
901.00
907.00
733.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,151.00
1,050.00
1,145.00
901.00
907.00
733.00
Expenditure (Ex Depriciation)
Stock Adjustments
-34.00
14.00
-7.00
-58.00
-16.00
0.00
Raw Materials Consumed
442.00
401.00
390.00
329.00
293.00
256.00
Power & Fuel Cost
52.00
56.00
52.00
40.00
38.00
33.00
Employee Cost
281.00
286.00
264.00
235.00
196.00
176.00
Operating Expenses
49.00
58.00
62.00
53.00
40.00
38.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
15.00
14.00
25.00
18.00
8.00
6.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
18.00
12.00
20.00
15.00
18.00
17.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
907.00
947.00
941.00
719.00
688.00
577.00
Operating Profit (PBDIT) excl Other Income
244.00
102.00
203.00
181.00
219.00
155.00
Other Income
8.00
17.00
14.00
30.00
16.00
13.00
Operating Profit (PBDIT)
252.00
119.00
218.00
211.00
236.00
169.00
Interest
91.00
58.00
41.00
21.00
4.00
3.00
Profit before Depriciation and Tax
160.00
61.00
176.00
189.00
232.00
165.00
Depreciation
107.00
95.00
79.00
53.00
43.00
42.00
Profit Before Taxation & Exceptional Items
52.00
-34.00
97.00
135.00
188.00
123.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
54.00
-38.00
102.00
195.00
188.00
135.00
Provision for Tax
22.00
-7.00
41.00
48.00
33.00
26.00
Profit After Tax
36.00
-27.00
64.00
147.00
154.00
117.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,001.00
1,043.00
991.00
842.00
707.00
595.00
Profit Available for appropriations
1,033.00
1,010.00
1,052.00
990.00
863.00
707.00
Appropriations
1,033.00
1,010.00
1,052.00
990.00
863.00
707.00
Equity Dividend (%)
0.00%
0.00%
110.00%
110.00%
110.00%
100.00%
Earnings Per Share
3.67
-3.75
7.26
18.13
19.15
13.77
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 54.09% vs 25.06% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 373.92% vs 159.75% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -61.73% vs -17.14% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 159.13% vs 154.44% in Mar 2024

Compare Profit and Loss Results of Shilpa Medicare
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,151.00
4,178.00
-3,027.00
-72.45%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,151.00
4,178.00
-3,027.00
-72.45%
Expenditure (Ex Depriciation)
Stock Adjustments
-34.00
12.00
-46.00
-383.33%
Raw Materials Consumed
442.00
2,537.00
-2,095.00
-82.58%
Power & Fuel Cost
52.00
160.00
-108.00
-67.50%
Employee Cost
281.00
646.00
-365.00
-56.50%
Operating Expenses
49.00
102.00
-53.00
-51.96%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
15.00
55.00
-40.00
-72.73%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
18.00
434.00
-416.00
-95.85%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
907.00
4,055.00
-3,148.00
-77.63%
Operating Profit (PBDIT) excl Other Income
244.00
122.00
122.00
100.00%
Other Income
8.00
34.00
-26.00
-76.47%
Operating Profit (PBDIT)
252.00
157.00
95.00
60.51%
Interest
91.00
50.00
41.00
82.00%
Profit before Depriciation and Tax
160.00
106.00
54.00
50.94%
Depreciation
107.00
125.00
-18.00
-14.40%
Profit Before Taxation & Exceptional Items
52.00
-19.00
71.00
373.68%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
54.00
-45.00
99.00
220.00%
Provision for Tax
22.00
-46.00
68.00
147.83%
Profit After Tax
36.00
0.00
36.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,001.00
638.00
363.00
56.90%
Profit Available for appropriations
1,033.00
634.00
399.00
62.93%
Appropriations
1,033.00
634.00
399.00
62.93%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.67
-0.28
3.95
1,410.71%
Profit And Loss - Net Sales
Net Sales 477.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 54.09% vs 25.06% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 124.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 373.92% vs 159.75% in Mar 2024

Profit And Loss - Interest
Interest 6.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -61.73% vs -17.14% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 69.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 159.13% vs 154.44% in Mar 2024